|
Originally published In Press as doi:10.1074/jbc.M407152200 on October 7, 2004
J. Biol. Chem., Vol. 279, Issue 51, 53442-53450, December 17, 2004
Limited Redundancy of the Proprotein Convertase Furin in Mouse Liver*
Anton J. M. Roebroek ,
Neil A. Taylor ,
Els Louagie ,
Ilse Pauli ,
Liesbeth Smeijers ,
An Snellinx¶,
Annick Lauwers ,
Wim J. M. Van de Ven||,
Dieter Hartmann¶, and
John W. M. Creemers **
From the
Experimental Mouse Genetics, Laboratory for Molecular Cell Biology, ¶Laboratory for Neuronal Cell Biology, ||Laboratory for Molecular Oncology, Department for Human Genetics, University of Leuven and Flanders Interuniversity Institute for Biotechnology, B-3000 Leuven, Belgium
Furin is an endoprotease of the family of mammalian proprotein convertases and is involved in the activation of a large variety of regulatory proteins by cleavage at basic motifs. A large number of substrates have been attributed to furin on the basis of in vitro and ex vivo data. However, no physiological substrates have been confirmed directly in a mammalian model system, and early embryonic lethality of a furin knock-out mouse model has precluded in vivo verification of most candidate substrates. Here, we report the generation and characterization of an interferon inducible Mx-Cre/loxP furin knock-out mouse model. Induction resulted in near-complete ablation of the floxed fur exon in liver.
In sharp contrast with the general furin knock-out mouse model, no obvious adverse effects were observed in the transgenic mice after induction. Histological analysis of the liver did not reveal any overt deviations from normal morphology. Analysis of candidate substrates in liver revealed complete redundancy for the processing of the insulin receptor. Variable degrees of redundancy were observed for the processing of albumin, 5 integrin, lipoprotein receptor-related protein, vitronectin and 1-microglobulin/bikunin. None of the tested substrates displayed a complete block of processing. The absence of a severe phenotype raises the possibility of using furin as a local therapeutic target in the treatment of pathologies like cancer and viral infections, although the observed redundancy may require combination therapy or the development of a more broad spectrum convertase inhibitor.
Received for publication, June 25, 2004
, and in revised form, October 6, 2004.
* This work was supported by grants and scholarships from the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" and the "Geconcerteerde Onderzoeksacties 2002-2006." The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed: Laboratory for Molecular Cell Biology, Dept. for Human Genetics, K.U. Leuven/V.I.B., Gasthuisberg O/N 6, Box 602, Herestraat 49, B-3000 Leuven, Belgium. Tel.: 32-16-346080; Fax: 32-16-346073; E-mail: john.creemers{at}med.kuleuven.ac.be.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
T. Komiyama, J. M. Coppola, M. J. Larsen, M. E. van Dort, B. D. Ross, R. Day, A. Rehemtulla, and R. S. Fuller
Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules
J. Biol. Chem.,
June 5, 2009;
284(23):
15729 - 15738.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Scamuffa, A Basak, C Lalou, A Wargnier, J Marcinkiewicz, G Siegfried, M Chretien, F Calvo, N G Seidah, and A-M Khatib
Regulation of prohepcidin processing and activity by the subtilisin-like proprotein convertases Furin, PC5, PACE4 and PC7
Gut,
November 1, 2008;
57(11):
1573 - 1582.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Louagie, N. A. Taylor, D. Flamez, A. J. M. Roebroek, N. A. Bright, S. Meulemans, R. Quintens, P. L. Herrera, F. Schuit, W. J. M. Van de Ven, et al.
Role of furin in granular acidification in the endocrine pancreas: Identification of the V-ATPase subunit Ac45 as a candidate substrate
PNAS,
August 26, 2008;
105(34):
12319 - 12324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fugere, J. Appel, R. A. Houghten, I. Lindberg, and R. Day
Short Polybasic Peptide Sequences Are Potent Inhibitors of PC5/6 and PC7: Use of Positional Scanning-Synthetic Peptide Combinatorial Libraries as a Tool for the Optimization of Inhibitory Sequences
Mol. Pharmacol.,
January 1, 2007;
71(1):
323 - 332.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Thimon, M. Belghazi, J.-L. Dacheux, and J.-L. Gatti
Analysis of furin ectodomain shedding in epididymal fluid of mammals: demonstration that shedding of furin occurs in vivo.
Reproduction,
December 1, 2006;
132(6):
899 - 908.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Benjannet, D. Rhainds, J. Hamelin, N. Nassoury, and N. G. Seidah
The Proprotein Convertase (PC) PCSK9 Is Inactivated by Furin and/or PC5/6A: FUNCTIONAL CONSEQUENCES OF NATURAL MUTATIONS AND POST-TRANSLATIONAL MODIFICATIONS
J. Biol. Chem.,
October 13, 2006;
281(41):
30561 - 30572.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Scamuffa, F. Calvo, M. Chretien, N. G. Seidah, and A.-M. Khatib
Proprotein convertases: lessons from knockouts
FASEB J,
October 1, 2006;
20(12):
1954 - 1963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Pesu, L. Muul, Y. Kanno, and J. J. O'Shea
Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma
Blood,
August 1, 2006;
108(3):
983 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Bauer, M. Humphries, R. Fassler, A. Winklmeier, S. E. Craig, and A.-K. Bosserhoff
Regulation of Integrin Activity by MIA
J. Biol. Chem.,
April 28, 2006;
281(17):
11669 - 11677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. M. Creemers, L. E. Pritchard, A. Gyte, P. Le Rouzic, S. Meulemans, S. L. Wardlaw, X. Zhu, D. F. Steiner, N. Davies, D. Armstrong, et al.
Agouti-Related Protein Is Posttranslationally Cleaved by Proprotein Convertase 1 to Generate Agouti-Related Protein (AGRP)83-132: Interaction between AGRP83-132 and Melanocortin Receptors Cannot Be Influenced by Syndecan-3
Endocrinology,
April 1, 2006;
147(4):
1621 - 1631.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Essalmani, J. Hamelin, J. Marcinkiewicz, A. Chamberland, M. Mbikay, M. Chretien, N. G. Seidah, and A. Prat
Deletion of the Gene Encoding Proprotein Convertase 5/6 Causes Early Embryonic Lethality in the Mouse
Mol. Cell. Biol.,
January 1, 2006;
26(1):
354 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tang, A. Mikhailik, I. Pauli, L. C. Giudice, A. T. Fazelabas, S. Tulac, D. D. Carson, D. G. Kaufman, C. Barbier, J. W. M. Creemers, et al.
Decidual Differentiation of Stromal Cells Promotes Proprotein Convertase 5/6 Expression and Lefty Processing
Endocrinology,
December 1, 2005;
146(12):
5313 - 5320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-M. Sun, E. R. Eden, I. Tosi, C. K. Neuwirth, D. Wile, R. P. Naoumova, and A. K. Soutar
Evidence for effect of mutant PCSK9 on apolipoprotein B secretion as the cause of unusually severe dominant hypercholesterolaemia
Hum. Mol. Genet.,
May 1, 2005;
14(9):
1161 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|